Active specific immunotherapy for melanoma: phase I trial of allogeneic lysates and a novel adjuvant.

Source:http://linkedlifedata.com/resource/pubmed/id/3262416

Cancer Res. 1988 Oct 15 48 20 5883-93

Download in:

View as

General Info

PMID
3262416